세계의 컨슈머 헬스케어 시장 보고서(2025년)
Consumer Healthcare Global Market Report 2025
상품코드 : 1821546
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

컨슈머 헬스케어 시장 규모는 향후 수년간 비약적인 성장이 전망됩니다. 2029년에는 CAGR 21.8%로 1조 8,008억 5,000만 달러로 성장합니다. 예측 기간의 성장은 개인 건강 및 유전학, 디지털 건강 및 원격의료, 원격 환자 모니터링, 건강 앱 및 웨어러블, 건강 보조 식품 및 영양 보조 식품에 대한 수요 증가에 기인합니다. 예측 기간의 주요 동향에는 디지털 헬스 및 원격의료, 건강 앱 및 웨어러블, 개인화된 건강 및 유전학, 원격 모니터링 기기 사용, 고령화 솔루션 채택 등이 포함됩니다.

향후 5년간 21.8%의 성장률 전망은 지난번 예측보다 0.2% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 멕시코와 태국에서 개발된 일반 의약품과 디지털 온도계의 가격을 급등시켜 가계 의료비를 증가시키고 예방 의료에 대한 접근성을 떨어뜨림으로써 미국의 셀프케어를 저해할 수 있습니다. 또한 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

E-Commerce와 온라인 약국의 확대 성장은 소비자 헬스케어 시장을 촉진하는 데 있으며, 매우 중요한 역할을 하고 있습니다. 소비자 헬스케어 제품은 소비자의 편의성을 살려 온라인 약국에서의 판매가 증가하고 있습니다. 주목할 만한 세계의 온라인 약국에는 Walgreens, Hims.com/Hers.com, SecurePharmaOnline, YourDrugStore, Lloyds Pharmacy, Netmeds 등이 있습니다. 또한 제약사들은 온라인 소매업에 적극적으로 진출하고 있으며, Dr. Reddy's와 같이 미국의 Amazon 및 기타 E-Commerce 채널과 같은 플랫폼을 통해 일반의약품(OTC)을 판매하는 사례도 있습니다. E-Commerce 활동의 급증은 소비자 헬스케어 시장 성장의 중요한 기폭제가 되고 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Consumer healthcare refers to personal healthcare products that are directly sold to consumers without requiring a prescription from a healthcare professional. This category typically includes over-the-counter (OTC) drugs, health supplements, cosmetics, disinfectants, and consumer medical devices.

The main products within the consumer healthcare market are over-the-counter (OTC) pharmaceuticals and dietary supplements. OTC drugs, also known as non-prescription medicines, can be purchased directly from a drug store without the need for a prescription. Dietary supplements are products designed to supplement and add nutrients to a person's diet. The consumer healthcare market is further segmented by application, including retail, online sales, and distribution through hospitals. This segmentation reflects the diverse channels through which consumers access and purchase healthcare products for personal use.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The consumer healthcare market research report is one of a series of new reports from The Business Research Company that provides consumer healthcare market statistics, including consumer healthcare market industry global market size, regional shares, competitors with consumer healthcare market share, detailed consumer healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the consumer healthcare market industry. This consumer healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The consumer healthcare market size has grown exponentially in recent years. It will grow from $667.56 billion in 2024 to $818.63 billion in 2025 at a compound annual growth rate (CAGR) of 22.6%. The growth in the historic period can be attributed to aging population and healthcare needs, over-the-counter (otc) medications, wellness and prevention focus, growth of e-commerce and online pharmacies, increasing health and fitness trends.

The consumer healthcare market size is expected to see exponential growth in the next few years. It will grow to $1800.85 billion in 2029 at a compound annual growth rate (CAGR) of 21.8%. The growth in the forecast period can be attributed to growing personalized health and genetics, digital health and telemedicine, remote patient monitoring, health apps and wearables, growing demand for nutraceuticals and dietary supplements. Major trends in the forecast period include adoption of digital health and telemedicine, health apps and wearables, personalized health and genetics, the use of remote monitoring devices, aging-in-place solutions.

The forecast of 21.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. self-care by inflating prices of over the counter(OTC) medications and digital thermometers developed in Mexico and Thailand, resulting in higher household healthcare expenses and reduced preventive care access. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The expansive growth of e-commerce and online pharmacies is playing a pivotal role in driving the consumer healthcare market. Consumer healthcare products are experiencing increased sales through online pharmacies, leveraging the convenience factor for consumers. Notable global online pharmacies include Walgreens, Hims.com/Hers.com, SecurePharmaOnline, YourDrugStore, Lloyds Pharmacy, and Netmeds. Furthermore, pharmaceutical companies are actively participating in the online retail space, with examples like Dr. Reddy's selling its over-the-counter (OTC) products through platforms such as Amazon and other e-commerce channels in the USA. The surge in e-commerce activities is a significant catalyst for the growth observed in the consumer healthcare market.

The increasing prevalence of cardiovascular diseases is anticipated to drive growth in the consumer healthcare market. Cardiovascular disease (CVD) is a general term that describes conditions affecting the heart or blood vessels. Consumer healthcare services are utilized in the management of cardiovascular diseases as they provide a convenient and cost-effective means to address the condition, with proper diagnosis, medication management, and lifestyle changes being essential elements of CVD care. For example, in March 2024, a report from the National Heart Foundation of Australia revealed that 1 in 6 Australians self-report living with cardiovascular disease (CVD), amounting to over 4.5 million individuals. Therefore, the rising prevalence of cardiovascular diseases is expected to drive the growth of the consumer healthcare market in the future.

Consumer healthcare companies are increasingly embracing digital health solutions to meet evolving consumer preferences. With the rising trend of digitization in health and wellness, consumer healthcare brands are introducing digital, connected, and personalized self-care solutions. For instance, Johnson & Johnson has introduced a behavioral coaching app as part of its Nicorette(R) QuickMist(R) Nicotine Spray, aiding smokers in planning and tracking their progress in quitting smoking. This strategic shift towards digital health solutions aligns with the changing landscape of consumer preferences, contributing to the continued growth of the consumer healthcare market.

Prominent companies within the consumer healthcare market are strategically directing their efforts towards product launches, exemplified by initiatives like Cedars-Sinai Connect, in response to the increasing demand for consumer healthcare services. Cedars-Sinai Connect stands out as an AI-powered virtual healthcare application designed to offer patients convenient and prompt access to specialists from Cedars-Sinai for a diverse range of health needs, covering acute illnesses, chronic conditions, and preventive care. A notable collaboration occurred in October 2023, when Cedars-Sinai, a US-based non-profit hospital, and K Health Inc., a US-based clinical AI-powered primary care company, jointly launched Cedars-Sinai Connect. This application is available to both new and existing patients in California, providing continuous access to virtual healthcare providers for immediate assistance with urgent matters and facilitating same-day scheduling for primary care appointments.

In October 2023, Bristol Myers Squibb, a biopharmaceutical company based in the U.S., acquired Mirati Therapeutics for a total equity value of $4.8 billion. This acquisition is intended to strengthen Bristol Myers Squibb's oncology portfolio, which features KRAZATI (adagrasib) for the treatment of non-small cell lung cancer. Mirati Therapeutics is also a U.S.-based biopharmaceutical company focused on developing innovative therapies for cancer treatment.

Major companies operating in the consumer healthcare market include Johnson & Johnson, Procter & Gamble, GlaxoSmithKline, Pfizer Inc., Bayer AG, Merck & Co. Inc., Reckitt Benckiser Group plc, Sanofi S.A., AbbVie Inc., Amgen Inc., Nestle Health Science, Church & Dwight Co. Inc., Colgate-Palmolive Company, Herbalife Nutrition Ltd., DSM (Dutch State Mines), Boiron, Perrigo Company plc, Meda Pharmaceuticals, Astellas Pharma Inc., Bausch Health Companies Inc., Ipsen S.A., HRA Pharma, Omega Pharma, Canopy Growth Corporation, Nature's Way, Oriflame Cosmetics S.A., Softel, Unilever PLC, Nature's Bounty

North America was the largest region in the consumer healthcare market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the consumer healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the Consumer Healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The consumer healthcare market consists of sales of medicated and non-medicated solutions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Consumer Healthcare Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on consumer healthcare market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for consumer healthcare ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The consumer healthcare market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Consumer Healthcare Market Characteristics

3. Consumer Healthcare Market Trends And Strategies

4. Consumer Healthcare Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Consumer Healthcare Growth Analysis And Strategic Analysis Framework

6. Consumer Healthcare Market Segmentation

7. Consumer Healthcare Market Regional And Country Analysis

8. Asia-Pacific Consumer Healthcare Market

9. China Consumer Healthcare Market

10. India Consumer Healthcare Market

11. Japan Consumer Healthcare Market

12. Australia Consumer Healthcare Market

13. Indonesia Consumer Healthcare Market

14. South Korea Consumer Healthcare Market

15. Western Europe Consumer Healthcare Market

16. UK Consumer Healthcare Market

17. Germany Consumer Healthcare Market

18. France Consumer Healthcare Market

19. Italy Consumer Healthcare Market

20. Spain Consumer Healthcare Market

21. Eastern Europe Consumer Healthcare Market

22. Russia Consumer Healthcare Market

23. North America Consumer Healthcare Market

24. USA Consumer Healthcare Market

25. Canada Consumer Healthcare Market

26. South America Consumer Healthcare Market

27. Brazil Consumer Healthcare Market

28. Middle East Consumer Healthcare Market

29. Africa Consumer Healthcare Market

30. Consumer Healthcare Market Competitive Landscape And Company Profiles

31. Consumer Healthcare Market Other Major And Innovative Companies

32. Global Consumer Healthcare Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Consumer Healthcare Market

34. Recent Developments In The Consumer Healthcare Market

35. Consumer Healthcare Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기